Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

Journal of Immunology

Volumn 178, Issue 4, 2007, Pages 2361-2369

  Hervas Stubbs, Sandra ^a,b   Rueda, Paloma ^c   Lopez, Lissette ^c   Leclerc, Claude ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c Inmunologia y Genetica Aplicada SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOLOGICAL ADJUVANT; INSECTICIDE; INTERFERON; RECOMBINANT PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; INSECT CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS LIKE AGENT;

EID: 33846909742     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.4.2361     Document Type: Article

References (42)

1. Andreadis, T. G., J. J. Becnel, and S. E. White. 2003. Infectivity and pathogenicity of a novel baculovirus, CuniNPV from Culex nigripalpus (Diptera: Culicidae) for thirteen species and four genera of mosquitoes. J. Med. Entomol. 40: 512-517.
2. Becnel, J., S. White, B. Moser, T. Fukuda, M. Rotstein, A. Undeen, and A. Cockburn. 2001. Epizootiology and transmission of a newly discovered baculovirus from the mosquitoes Culex nigripalpus and C. quinquefasciatus. J. Gen. Virol. 82: 275-282.
3. Tjia, S. T., G. M. zu Altenschildesche, and W. Doerfler. 1983. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 125: 107-117.
4. Thiem, S. M. 1997. Prospects for altering host range for baculovirus bioinsecticides. Curr. Opin. Biotechnol. 8: 317-322.
5. Kost, T. A., J. P. Condreay, and D. L. Jarvis. 2005. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 23: 567-575.
6. Cruz, P. E., L. Maranga, and M. J. Carrondo. 2002. Integrated process optimization: lessons from retrovirus and virus-like particle production. J. Biotechnol. 99: 199-214.
7. Pattenden, L. K., A. P. Middelberg, M. Niebert, and D. I. Lipin. 2005. Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol. 23: 523-529.
8. Pushko, P., T. M. Tumpey, F. Bu, J. Knell, R. Robinson, and G. Smith. 2005. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 23: 5751-5759.
9. Rueda, P., J. Fominaya, J. P. Langeveld, C. Bruschke, C. Vela, and J. I. Casal. 2000. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 19: 726-734.
10. Abe, T., H. Hemmi, H. Miyamoto, K. Moriishi, S. Tamura, H. Takaku, S. Akira, and Y. Matsuura. 2005. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J. Virol. 79: 2847-2858.
11. Abe, T., H. Takahashi, H. Hamazaki, N. Miyano-Kurosaki, Y. Matsuura, and H. Takaku. 2003. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J. Immunol. 171: 1133-1139.
12. Gronowski, A. M., D. M. Hilbert, K. C. Sheehan, G. Garotta, and R. D. Schreiber. 1999. Baculovirus stimulates antiviral effects in mammalian cells. J. Virol. 73: 9944-9951.
13. Sedlik, C., M. Saron, J. Sarraseca, I. Casal, and C. Leclerc. 1997. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc. Natl. Acad. Sci. USA 94: 7503-7508.
14. + T cell epitope requires an adjuvant signal. J. Immunol. 174: 3432-3439.
15. + T cell responses in vivo after viral stimulation. Blood 104: 1808-1815.
16. Bahnemann, H. G. 1990. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 8: 299-303.
17. Liu, F., L. M. Shollenberger, and L. Huang. 2004. Non-immunostimulatory non-viral vectors. FASEB J. 18: 1779-1781.
18. Baumert, T. F., J. Vergalla, J. Satoi, M. Thomson, M. Lechmann, D. Herion, H. B. Greenberg, S. Ito, and T. J. Liang. 1999. Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology 117: 1397-1407.
19. Christensen, J., S. Alexandersen, B. Bloch, B. Aasted, and A. Uttenthal. 1994. Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink. J. Gen. Virol. 75(Pt. 1): 149-155.
20. Harro, C. D., Y. Y. Pang, R. B. Roden, A. Hildesheim, Z. Wang, M. J. Reynolds, T. C. Mast, R. Robinson, B. R. Murphy, R. A. Karron, et al. 2001. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 93: 284-292.
21. Koutsky, L. A., K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, and K. U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347: 1645-1651.
22. + T cells and subsequently express CD8α and CD205 molecules. J. Exp. Med. 195: 1233-1245.
23. Plana-Duran, J., M. Bastons, M. J. Rodriguez, I. Climent, E. Cortes, C. Vela, and I. Casal. 1996. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease. Arch. Virol. 141: 1423-1436.
24. Zhang, L. F., J. Zhou, S. Chen, L. L. Cai, Q. Y. Bao, F. Y. Zheng, J. Q. Lu, J. Padmanabha, K. Hengst, K. Malcolm, and I. H. Frazer. 2000. HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine 18: 1051-1058.
25. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81: 2341-2364.
26. Evans, T. G., W. Bonnez, R. C. Rose, S. Koenig, L. Demeter, J. A. Suzich, D. O'Brien, M. Campbell, W. I. White, J. Balsley, and R. C. Reichman. 2001. A Phase I study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers. J. Infect. Dis. 183: 1485-1493.
27. Taniguchi, T., and A. Takaoka. 2002. The interferon α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14: 111-116.
28. Arico, E., E. Wang, M. L. Tornesello, M. Tagliamonte, G. K. Lewis, F. M. Marincola, F. M. Buonaguro, and L. Buonaguro. 2005. Immature monocyte derived dendritic cells gene expression profile in response to virus-like particles stimulation. J. Transl. Med. 3: 45.
29. Lenz, P., P. M. Day, Y. Y. Pang, S. A. Frye, P. N. Jensen, D. R. Lowy, and J. T. Schiller. 2001. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 166: 5346-5355.
30. Lenz, P., D. R. Lowy, and J. T. Schiller. 2005. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells. Eur. J. Immunol. 35: 1548-1556.
31. Warrino, D. E., W. C. Olson, M. I. Scarrow, L. J. D'Ambrosio-Brennan, R. S. Guido, D. M. Da Silva, W. M. Kast, and W. J. Storkus. 2005. Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro. Hum. Immunol. 66: 762-772.
32. Yang, R., F. M. Murillo, H. Cui, R. Blosser, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. Roden. 2004. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce α interferon and Th1 immune responses via MyD88. J. Virol. 78: 11152-11160.
33. + T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4: 1009-1015.
34. Le Bon, A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D. F. Tough. 2001. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470.
35. Honda, K., S. Sakaguchi, C. Nakajima, A. Watanabe, H. Yanai, M. Matsumoto, T. Ohteki, T. Kaisho, A. Takaoka, S. Akira, et al. 2003. Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl. Acad. Sci. USA 100: 10872-10877.
36. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469.
37. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
38. + T cell response during cross-priming. J. Immunol. 176: 4682-4689.
39. Le Bon, A., C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U. Kalinke, and D. F. Tough. 2006. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176: 2074-2078.
40. Tani, H., M. Nishijima, H. Ushijima, T. Miyamura, and Y. Matsuura. 2001. Characterization of cell-surface determinants important for baculovirus infection. Virology 279: 343-353.
41. Jarvis, D. L., and E. E. Finn. 1995. Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells. Virology 212: 500-511.
42. Apostolopoulos, V., and I. F. McKenzie. 2001. Role of the mannose receptor in the immune response. Curr. Mol. Med. 1: 469-474.